You searched for apixaban - MPR

Your search for apixaban returned 102 results

Sort Results:

Relevant Recent

News

Apixaban Tied to Lower Risk for Recurrent VTE in Dialysis Population

May 4, 2022

Apixaban is a direct oral anticoagulant that relies less on kidney excretion.

News

DOACs Cut Recurrent VTE in Adults With Cancer-Related Thrombosis

February 18, 2022

Direct oral anticoagulants reduce recurrent VTE events by 41 percent, with no significant increase in major bleeding, compared to dalteparin

Clinical Charts

Antiretroviral Contraindications and Drug Interactions

February 15, 2022

A list of contraindications and drug interactions for HIV medications.

News

Rates of Recurrent VTE Compared for Apixaban, Rivaroxaban

December 7, 2021

Among new users, rates of recurrent venous thromboembolism, GI and intracranial bleeding lower with apixaban than rivaroxaban

Clinical Charts

Thromboembolic Disorder Assessment: DVT/PE

December 1, 2021

Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).

Clinical Charts

High-Alert Medications

November 15, 2021

High-Alert Medications according to ISMP guidelines

Clinical Charts

Anticoagulant Dosing Conversions

November 15, 2021

Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.

Drug Monograph

ELIQUIS

Apixaban 2.5mg, 5mg; tabs.

News

Antithrombotic Therapy Not Helpful for COVID-19 Outpatients

October 19, 2021

Major adverse cardiopulmonary outcomes not reduced with aspirin, apixaban versus placebo for clinically stable COVID-19 outpatients

News

GI Bleeding Up for New Users of Rivaroxaban

October 13, 2021

Compared with other DOACs, rivaroxaban linked to higher rates of GI bleeding overall and in an analysis restricted to patients with atrial fibrillation